quatuor 07:06, 21 octobre 2022
WHO recommends against the use of remdesivir in COVID-19 patients https://www.who.int/news-room/feature-stories/detail/who-recommends-against-the-use-of-remdesivir-in-covid-19-patients Updated 20 November 2020 * A conditional recommendation is issued when the evidence around the benefits and risks of an intervention are less certain. In this case, there is a conditional recommendation against the use of remdesivir. This means that there isn’t enough evidence to support its use. 1. Who in the DOH recommends the use of Remdesivir to treat Covid-19? Provide us copy of recommendation.
Officier réceptionnaire 10:00, 21 octobre 2022
October 21, 2022 Dear Ryan, Thank you for your request dated Oct 21, 2022 under Executive Order No. 2 (s. 2016) on Freedom of Information in the Executive Branch, for WHO recommends against the use of Remdesivir in COVID-19 Part 2 patients Part 2. We received your request on Oct 21, 2022 and will respond on or before Nov 11, 2022 07:06:04 AM, in accordance with the Executive Order's implementing rules and regulations. Should you have any questions regarding your request, kindly contact me using the reply function on the eFOI portal at https://pcoomaster02202018193000-dot-efoi-ph.appspot.com/requests/aglzfmVmb2ktcGhyHQsSB0NvbnRlbnQiEERPSC0xOTY3NTk0NjAxMTYM, for request with ticket number #DOH-196759460116. Thank you. Respectfully, FOI Receiving Officer FOI Officer
